June 27, 2017

Selexis Announces Commercial License Agreement with Takeda for the Development of Fusion Proteins

Read More
June 14, 2017

JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer Selexis SA and Integrate Selexis with KBI Biopharma, Inc.

Read More
June 12, 2017

Selexis SA and TeneoBio, Inc. Team Up to Advance the Development of UniAbs Targeting Cancer

Read More

Media Downloads